KRYS
#916
Krystal Biotech, Inc. - Common Stock
339.4 3 USD
-0.07%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
-6.61%
Changement Mensuel
+3.55%
Evolution sur 6 mois
+19.45%
Changement Annuel
+81.39%
Clôture Précédente
363.4 4
Open
339.4 3
Low
339.4 3
High
339.4 3
Volume
151
Financials
- Market Capitalization 10.01 B
- Employee 295
- Founded 2016
- CEO N/A
- Website www.krystalbio.com
- Headquarter Pennsylvania, United States
- FIGI BBG00HDGRHH7
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
34.58
ratio cours/chiffre d'affaires
18.59
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 907 |  CYTK Cytokinetics, Incorporated - Common Stock | 81.93 USD | -0.38% | -3.61% | +12.23% | +41.02% | 10.19 B USD | ||
| 909 |  ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 71.91 USD | -2.97% | -16.26% | -7.28% | +83.91% | 10.13 B USD | ||
| 925 |  NUVL Nuvalent, Inc. - Class A Common Stock | 123.96 USD | +0.02% | +0.18% | +0.45% | +30.55% | 9.79 B USD | ||
| 930 |  CORT Corcept Therapeutics Incorporated - Common Stock | 90.47 USD | +5.32% | -2.47% | +8.76% | +23.31% | 9.71 B USD |